https://www.mediconvillage.se/sv/amniotics-featured-tv4-their-novel-source-mscs-treat-covid-19
Amniotics was recently featured in Swedish TV4, in regard to development of our cell-therapeutic for COVID-19 diseases. Studies have shown that mesenchymal stem cells can reduce patients time in ventilators. Hence, with our potent and lung selected PulmiCell product, we trust that we can make a differences for patients in need.
